Tag Archives: T-regulatory cell engineering

Innovative Partnership: AstraZeneca and Quell Therapeutics Targeting Autoimmune Diseases with Engineered Treg Cell Therapies

(IN BRIEF) AstraZeneca and Quell Therapeutics have announced a collaboration to develop innovative treatments for Type 1 Diabetes and Inflammatory Bowel Disease. Quell’s T-regulatory cell engineering technology will be used to create potential curative therapies. AstraZeneca has the option to … Read the full press release